IONSYS
Total Payments
$255,060
Transactions
733
Doctors
476
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $1,024 | 1 | 0 |
| 2017 | $254,036 | 732 | 476 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $95,685 | 24 | 37.5% |
| Unspecified | $54,882 | 21 | 21.5% |
| Honoraria | $53,575 | 20 | 21.0% |
| Food and Beverage | $19,890 | 617 | 7.8% |
| Education | $19,800 | 6 | 7.8% |
| Travel and Lodging | $11,228 | 45 | 4.4% |
Payments by Type
General
$200,178
712 transactions
Research
$54,882
21 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SAFETY AND CLINICAL UTILITY STUDY OF SSEC FENTANYL 40 MCG FOR ACUTE POST-OP PAIN MANAGEMENT IN PEDIATRIC PARTICIPANTS | The Medicines Company | $31,925 | 0 |
| SAFETY AND CLINICAL UTILITY STUDY OF SSEC FENTANYL 40 MCG FOR ACUTE POST-OP PAIN MANAGEMENT IN PEDIATRIC PATIENTS | The Medicines Company | $14,670 | 0 |
| An open label, evaluation of the satiety and clinical utility of the active. separated system with enhanced controller SSEC fentanyl. 40 meg for the management of acute postoperative pain in pediatric patients 12 to less than 18 years of age | The Medicines Company | $6,063 | 0 |
| 21720040 Assessing the Association between Patients' Perceptions of Success with Post-Operative Pain Management and Overall Experience with Care | The Medicines Company | $1,200 | 0 |
| An open label evaluation of the safety and clinical utility of the active, separated system with enhanced controller SSEC fentanyl 40 mcg for the management of acute postoperative pain in pediatric patients 12 to less than 18 years of age | The Medicines Company | $1,024 | 0 |
Top Doctors Receiving Payments for IONSYS — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Colon & Rectal Surgery | Cleveland, OH | $142.95 | 2 |
| , D.O | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Tulsa, OK | $141.34 | 2 |
| , MD | Surgery | Zeeland, MI | $140.55 | 2 |
| , M.D | Surgery | Melbourne, FL | $139.80 | 2 |
| , M.D | Anesthesiology | Oak Brook, IL | $135.34 | 5 |
| , DO | Adult Reconstructive Orthopaedic Surgery | Oklahoma City, OK | $123.95 | 1 |
| , DO | Anesthesiology | Stony Brook, NY | $123.12 | 2 |
| , MD | Colon & Rectal Surgery | Grand Rapids, MI | $121.52 | 1 |
| , MD | Surgery | Grand Rapids, MI | $121.52 | 1 |
| Theodore Stanley | — | Salt Lake City, UT | $117.66 | 1 |
| , MD | Gynecology | Southaven, MS | $116.66 | 1 |
| , MD | Cardiovascular Disease | Mayfield Hgts, OH | $114.81 | 2 |
| , MD | Anesthesiology | Stony Brook, NY | $113.55 | 2 |
| , M.D | Obstetrics & Gynecology | Bel Air, MD | $111.05 | 1 |
| , MD | Surgery | Suffern, NY | $106.15 | 1 |
| , M.D | Surgery | Suffern, NY | $106.15 | 1 |
| , M.D | Anesthesiology | Suffern, NY | $106.15 | 1 |
| , M.D | Anesthesiology | Stony Brook, NY | $105.35 | 1 |
| , MD | Anesthesiology | Stony Brook, NY | $105.35 | 1 |
| , MD | Anesthesiology | Stony Brook, NY | $105.35 | 1 |
| , MD | Obstetrics & Gynecology | Toledo, OH | $104.57 | 1 |
| , DO | Student in an Organized Health Care Education/Training Program | Toledo, OH | $104.57 | 1 |
| , MD | Anesthesiology | Maumee, OH | $104.57 | 1 |
| , M.D | Internal Medicine | Las Vegas, NV | $102.33 | 1 |
| , D.O | Orthopaedic Surgery | Las Vegas, NV | $102.33 | 1 |
Ad
Manufacturing Companies
- The Medicines Company $255,060
Product Information
- Type Drug
- Total Payments $255,060
- Total Doctors 476
- Transactions 733
About IONSYS
IONSYS is a drug associated with $255,060 in payments to 476 healthcare providers, recorded across 733 transactions in the CMS Open Payments database. The primary manufacturer is The Medicines Company.
Payment data is available from 2017 to 2018. In 2018, $1,024 was paid across 1 transactions to 0 doctors.
The most common payment nature for IONSYS is "Consulting Fee" ($95,685, 37.5% of total).
IONSYS is associated with 5 research studies, including "SAFETY AND CLINICAL UTILITY STUDY OF SSEC FENTANYL 40 MCG FOR ACUTE POST-OP PAIN MANAGEMENT IN PEDIATRIC PARTICIPANTS" ($31,925).